Tag:
Alere
Latest Headlines
Latest Headlines
Alere snags up to $42.2M from Gates Foundation for TB Dx
Diagnostics magnate Alere has hooked up with the Bill and Melinda Gates Foundation to develop a tuberculosis assay and support its point-of-care HIV test.
Website reveals device makers that dodge excise tax costs
Allergan, Cerner, Waters, Alere, Invacare, Integra Lifescience and Misonex are just a few of the medical device companies passing on the cost of the industry's 2.3% excise tax onto their hospital customers, and a major hospital purchasing group wants you to know about it.
Acquisitions help boost Alere's 2012 Q4 revenue
Alere ($ALR) says its fourth quarter 2012 net revenue surged to nearly $756 million, up substantially from $651 million over the same period in 2011, thanks in part to acquisitions in the diagnostics space.
UPDATED: 2012's Top 10 Diagnostics Companies
When industry folks look back at 2012, they may well see it as the year that diagnostics companies reached a rock-star-like status in the life sciences industry. Check out the report >>
FDA warns Alere for cardiac DX quality shortfalls
The FDA is taking Alere ($ALR) to task for not acting fast enough to address manufacturing problems with its Triage cardiac diagnostic products.
Alere strikes deal with FDA on Dx manufacturing
Diagnostics company Alere says it has reached an agreement with the FDA over production of its Triage cardiac tests, after recalling thousands of the kits in May over quality control concerns.
Recall, charges negate Alere's revenue growth in Q2
Diagnostics firm Alere reported sales growth in most of its units in the second quarter, but all that was negated by charges and the fallout from its heart test recall.
Alere recalls thousands of cardiac diagnostic tests
Alere ($ALR) has entered uncertain territory this week as it launches a recall for 104 lots of its cardiac diagnostic tests (803,000 in all), following FDA concerns over quality control methods used in their production.
Heart attack test alert from Alere
More than 800,000 heart meters used to detect heart attacks are being recalled by Waltham, MA-based Alere ($ALR) after FDA inspectors found manufacturing and labeling issues at its San Diego plant.
Axis-Shield, CVS Caremark's MinuteClinic ink deal
Axis-Shield has agreed to provide an Afinion analyzer for each of the approximately 600 CVS MinuteClinic locations in the U.S. so diabetes patients can obtain access to hemoglobin A1c test results
